[PHARMA] QoQ TTM Result on 31-Mar-2018 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-May-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Mar-2018 [#1]
Profit Trend
QoQ- -2.49%
YoY- 13.53%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 2,384,956 2,401,508 2,388,351 2,323,589 2,323,960 2,293,580 2,234,292 4.43%
PBT 70,220 78,146 75,814 73,994 73,064 57,267 61,919 8.72%
Tax -26,990 -17,398 -26,481 -20,676 -18,077 -25,268 -21,162 17.55%
NP 43,230 60,748 49,333 53,318 54,987 31,999 40,757 3.99%
-
NP to SH 42,468 59,731 48,260 52,386 53,723 31,187 40,668 2.92%
-
Tax Rate 38.44% 22.26% 34.93% 27.94% 24.74% 44.12% 34.18% -
Total Cost 2,341,726 2,340,760 2,339,018 2,270,271 2,268,973 2,261,581 2,193,535 4.44%
-
Net Worth 509,862 522,618 519,642 524,838 526,888 531,892 542,147 -3.99%
Dividend
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Div 41,587 51,957 51,929 51,913 49,290 41,490 38,883 4.57%
Div Payout % 97.93% 86.99% 107.60% 99.10% 91.75% 133.04% 95.61% -
Equity
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Net Worth 509,862 522,618 519,642 524,838 526,888 531,892 542,147 -3.99%
NOSH 260,505 260,505 259,821 259,821 259,821 259,821 259,400 0.28%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 1.81% 2.53% 2.07% 2.29% 2.37% 1.40% 1.82% -
ROE 8.33% 11.43% 9.29% 9.98% 10.20% 5.86% 7.50% -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 916.82 923.62 919.23 894.30 895.38 883.98 861.33 4.23%
EPS 16.33 22.97 18.57 20.16 20.70 12.02 15.68 2.73%
DPS 16.00 20.00 20.00 20.00 19.00 16.00 15.00 4.38%
NAPS 1.96 2.01 2.00 2.02 2.03 2.05 2.09 -4.17%
Adjusted Per Share Value based on latest NOSH - 259,821
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 165.48 166.63 165.72 161.22 161.25 159.14 155.03 4.43%
EPS 2.95 4.14 3.35 3.63 3.73 2.16 2.82 3.04%
DPS 2.89 3.61 3.60 3.60 3.42 2.88 2.70 4.62%
NAPS 0.3538 0.3626 0.3606 0.3642 0.3656 0.3691 0.3762 -3.99%
Price Multiplier on Financial Quarter End Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 -
Price 2.78 2.89 2.88 4.28 4.60 4.14 4.58 -
P/RPS 0.30 0.31 0.31 0.48 0.51 0.47 0.53 -31.50%
P/EPS 17.03 12.58 15.51 21.23 22.22 34.44 29.21 -30.14%
EY 5.87 7.95 6.45 4.71 4.50 2.90 3.42 43.21%
DY 5.76 6.92 6.94 4.67 4.13 3.86 3.28 45.40%
P/NAPS 1.42 1.44 1.44 2.12 2.27 2.02 2.19 -25.02%
Price Multiplier on Announcement Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 15/11/17 16/08/17 -
Price 2.76 3.09 3.11 4.07 4.04 3.82 4.19 -
P/RPS 0.30 0.33 0.34 0.46 0.45 0.43 0.49 -27.83%
P/EPS 16.91 13.45 16.74 20.19 19.52 31.78 26.73 -26.24%
EY 5.92 7.43 5.97 4.95 5.12 3.15 3.74 35.70%
DY 5.80 6.47 6.43 4.91 4.70 4.19 3.58 37.82%
P/NAPS 1.41 1.54 1.56 2.01 1.99 1.86 2.00 -20.73%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment